TMEM255A

gene
On this page

Also known as FLJ20716

Summary

TMEM255A (transmembrane protein 255A, HGNC:26086) is a protein-coding gene on chromosome Xq24, encoding Transmembrane protein 255A (Q5JRV8).

Predicted to act upstream of or within response to bacterium. Predicted to be located in membrane.

Source: NCBI Gene 55026 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 214 total
  • MANE Select transcript: NM_001104544

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26086
Approved symbolTMEM255A
Nametransmembrane protein 255A
LocationXq24
Locus typegene with protein product
StatusApproved
AliasesFLJ20716
Ensembl geneENSG00000125355
Ensembl biotypeprotein_coding
Entrez55026

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 10 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000309720, ENST00000371352, ENST00000371369, ENST00000440464, ENST00000480821, ENST00000519908, ENST00000891651, ENST00000891652, ENST00000891653, ENST00000924824, ENST00000949560

RefSeq mRNA: 3 — MANE Select: NM_001104544 NM_001104544, NM_001104545, NM_017938

CCDS: CCDS14597, CCDS43986, CCDS48157

Canonical transcript exons

ENST00000371369 — 9 exons

ExonStartEnd
ENSE00000854515120268244120268387
ENSE00000899864120276885120277047
ENSE00000899865120285127120285215
ENSE00001038040120291251120291340
ENSE00001038044120304349120304491
ENSE00001038046120293989120294051
ENSE00001038047120287154120287222
ENSE00001836733120258650120261028
ENSE00003910068120311252120311461

Expression profiles

Bgee: expression breadth ubiquitous, 211 present calls, max score 97.57.

FANTOM5 (CAGE): breadth broad, TPM avg 3.5470 / max 138.0088, expressed in 594 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
2003401.8009457
2003411.7132479
2003420.032910

Top tissues by expression

274 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
substantia nigra pars reticulataUBERON:000196697.57gold quality
substantia nigra pars compactaUBERON:000196597.26gold quality
dorsal root ganglionUBERON:000004495.14gold quality
superior vestibular nucleusUBERON:000722791.37gold quality
germinal epithelium of ovaryUBERON:000130490.85gold quality
substantia nigraUBERON:000203889.78gold quality
midbrainUBERON:000189188.93gold quality
hypothalamusUBERON:000189888.89gold quality
medulla oblongataUBERON:000189687.55gold quality
ponsUBERON:000098886.88gold quality
trigeminal ganglionUBERON:000167585.65gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.77silver quality
dorsal motor nucleus of vagus nerveUBERON:000287084.21gold quality
spinal cordUBERON:000224083.58gold quality
inferior olivary complexUBERON:000212783.19silver quality
C1 segment of cervical spinal cordUBERON:000646982.70gold quality
left ovaryUBERON:000211982.43gold quality
right ovaryUBERON:000211881.59gold quality
ovaryUBERON:000099280.42gold quality
ectocervixUBERON:001224979.47gold quality
tibial nerveUBERON:000132378.65gold quality
ventral tegmental areaUBERON:000269178.58gold quality
nucleus accumbensUBERON:000188277.65gold quality
urethraUBERON:000005776.50gold quality
amygdalaUBERON:000187676.44gold quality
sural nerveUBERON:001548876.44gold quality
endocervixUBERON:000045875.84gold quality
vaginaUBERON:000099675.39gold quality
subthalamic nucleusUBERON:000190674.08gold quality
pigmented layer of retinaUBERON:000178273.28gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.32
E-MTAB-6911no124.62

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

188 targeting TMEM255A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4682100.0068.891258
HSA-MIR-4262100.0073.263931
HSA-MIR-34A-5P99.9971.211784
HSA-MIR-449A99.9971.051776
HSA-MIR-511-3P99.9968.851467
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-548AW99.9972.573559
HSA-MIR-480399.9871.993117
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-56899.9869.862084
HSA-MIR-548P99.9872.253784
HSA-MIR-32-5P99.9875.211964
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-25-3P99.9874.601817
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-34C-5P99.9770.451577
HSA-MIR-449B-5P99.9770.261580
HSA-MIR-50799.9770.111915
HSA-MIR-365899.9673.874379
HSA-MIR-9-3P99.9670.882068
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-590-3P99.9674.346478
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotmem255aENSDARG00000073911
mus_musculusTmem255aENSMUSG00000036502
rattus_norvegicusTmem255aENSRNOG00000028085

Protein

Protein identifiers

Transmembrane protein 255AQ5JRV8 (reviewed: Q5JRV8)

Alternative names: Protein FAM70A

All UniProt accessions (2): Q5JRV8, E5RFR0

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the TMEM255 family.

Isoforms (4)

UniProt IDNamesCanonical?
Q5JRV8-11yes
Q5JRV8-22
Q5JRV8-33
Q5JRV8-44

RefSeq proteins (3): NP_001098014, NP_001098015, NP_060408 (=MANE)

Domains & families (InterPro)

IDNameType
IPR028014TMEM255Family

Pfam: PF14967

UniProt features (13 total): transmembrane region 4, splice variant 4, chain 1, sequence variant 1, sequence conflict 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5JRV8-F165.640.19

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 208 (showing top): TGGTGCT_MIR29A_MIR29B_MIR29C, E2F_Q4_01, LEE_NEURAL_CREST_STEM_CELL_DN, WWTAAGGC_UNKNOWN, TGCGCANK_UNKNOWN, MODULE_255, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, ZHAN_MULTIPLE_MYELOMA_MF_UP, SP3_Q3, MODULE_317, IVANOVA_HEMATOPOIESIS_MATURE_CELL, AP4_Q6, LHX3_01, CAGCTG_AP4_Q5, SENESE_HDAC1_AND_HDAC2_TARGETS_DN

GO Biological Process (1): response to bacterium (GO:0009617)

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
response to other organism1
cellular anatomical structure1

Protein interactions and networks

STRING

464 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM255AFZD8Q9H461516
TMEM255ASDC4P31431508
TMEM255ALIX1Q8N485469
TMEM255AFURINP09958466
TMEM255AANKUB1A6NFN9429
TMEM255ASLC35E4Q6ICL7417
TMEM255ALRRC71Q8N4P6394
TMEM255AGPATCH11Q8N954393
TMEM255AFAM216BQ8N7L0363
TMEM255AANKRD66B4E2M5361
TMEM255AATP1B4Q9UN42353
TMEM255AEFCC1Q9HA90348
TMEM255APDIK1LQ8N165342
TMEM255ARSPO3Q9BXY4341
TMEM255ADYNLT5Q8N7M0324

IntAct

4 interactions, top by confidence:

ABTypeScore
TMEM255AWWP2psi-mi:“MI:0914”(association)0.530
TMEM255ACANXpsi-mi:“MI:0914”(association)0.350

BioGRID (31): SEC24B (Affinity Capture-MS), WWP2 (Affinity Capture-MS), ITCH (Affinity Capture-MS), WWP1 (Affinity Capture-MS), COLGALT2 (Affinity Capture-MS), NEDD4 (Affinity Capture-MS), KCTD2 (Affinity Capture-MS), GCA (Affinity Capture-MS), UBASH3B (Affinity Capture-MS), ANKRD13D (Affinity Capture-MS), GCA (Affinity Capture-MS), KCTD2 (Affinity Capture-MS), ANKRD13D (Affinity Capture-MS), ITCH (Affinity Capture-MS), WWP1 (Affinity Capture-MS)

ESM2 similar proteins: A0A1B0GW64, A2AFR3, A4IFL2, A6QLZ5, A8MVS5, A8MWV9, E1BBQ2, E9Q2Z6, O54693, O73612, P01134, P0C8R9, P18519, P48030, P52795, P52796, P98172, Q0VAQ4, Q0VBP7, Q14CM0, Q15223, Q3MHZ5, Q4FZH1, Q4R566, Q5JRV8, Q5R8M2, Q5RB29, Q5T1S8, Q5T292, Q5VX71, Q6AYP5, Q7TPF1, Q8BHW5, Q8BR63, Q8CA71, Q8IVY1, Q8R5M8, Q91WM6, Q91XV6, Q96DD7

Diamond homologs: Q5FW56, Q5JRV8, Q66IQ1, Q7TMP6, Q8BHW5, Q8WV15, Q9BE63

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

214 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance75
Likely benign3
Benign4

Top pathogenic / likely-pathogenic (0)

SpliceAI

1465 predictions. Top by Δscore:

VariantEffectΔscore
X:120268239:CATA:Cdonor_loss1.0000
X:120268240:ATAC:Adonor_loss1.0000
X:120268241:TA:Tdonor_loss1.0000
X:120268242:A:AGdonor_loss1.0000
X:120268243:C:CGdonor_loss1.0000
X:120268386:TTC:Tacceptor_loss1.0000
X:120268387:TCTG:Tacceptor_loss1.0000
X:120268388:C:Tacceptor_loss1.0000
X:120268389:T:Aacceptor_loss1.0000
X:120276878:T:Adonor_gain1.0000
X:120276879:CCTTA:Cdonor_loss1.0000
X:120276880:CTTAC:Cdonor_loss1.0000
X:120276881:TTA:Tdonor_loss1.0000
X:120276882:TACC:Tdonor_loss1.0000
X:120276883:A:ACdonor_gain1.0000
X:120276883:ACCAT:Adonor_loss1.0000
X:120276884:C:CCdonor_gain1.0000
X:120277043:CCCGG:Cacceptor_gain1.0000
X:120277044:CCGG:Cacceptor_gain1.0000
X:120277044:CCGGC:Cacceptor_gain1.0000
X:120277045:CGG:Cacceptor_gain1.0000
X:120277045:CGGC:Cacceptor_gain1.0000
X:120277048:C:CCacceptor_gain1.0000
X:120291337:CCAG:Cacceptor_gain1.0000
X:120291338:CAGC:Cacceptor_gain1.0000
X:120311247:CTTA:Cdonor_loss1.0000
X:120311248:TTA:Tdonor_loss1.0000
X:120311249:TA:Tdonor_loss1.0000
X:120311250:A:ACdonor_gain1.0000
X:120311250:AC:Adonor_gain1.0000

AlphaMissense

2107 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:120276904:A:GL243P1.000
X:120276910:G:TA241D1.000
X:120276913:G:TA240D1.000
X:120276925:C:TG236D1.000
X:120276926:C:GG236R1.000
X:120276934:A:GL233P1.000
X:120276938:C:GG232R1.000
X:120276945:G:CN229K1.000
X:120276945:G:TN229K1.000
X:120276967:A:GL222P1.000
X:120276970:A:GL221P1.000
X:120276979:A:GL218P1.000
X:120276997:C:GC212S1.000
X:120276998:A:TC212S1.000
X:120287194:C:GC128S1.000
X:120287195:A:TC128S1.000
X:120291274:C:GG111R1.000
X:120291274:C:TG111R1.000
X:120291276:T:AD110V1.000
X:120291276:T:CD110G1.000
X:120291276:T:GD110A1.000
X:120291277:C:AD110Y1.000
X:120291277:C:GD110H1.000
X:120291289:A:GC106R1.000
X:120291309:C:AG99V1.000
X:120291309:C:TG99D1.000
X:120291310:C:AG99C1.000
X:120291310:C:GG99R1.000
X:120291314:G:CS97R1.000
X:120291314:G:TS97R1.000

dbSNP variants (sampled 300 via entrez): RS1000053298 (X:120272345 T>C), RS1000278739 (X:120252114 C>T), RS1000415724 (X:120252665 A>G), RS1000518018 (X:120266332 C>A), RS1000598945 (X:120266652 A>G), RS1000725191 (X:120255428 T>G), RS1000947204 (X:120310168 G>A), RS1001017380 (X:120300550 G>C), RS1001107940 (X:120290550 T>C), RS1001679949 (X:120295625 A>G), RS1001783266 (X:120286455 G>T), RS1002052897 (X:120298940 G>T), RS1002110375 (X:120288706 C>T), RS1002119299 (X:120296034 A>G), RS1002423510 (X:120298387 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST90002393_598Monocyte count1.000000e-10
GCST90002407_382White blood cell count1.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0005091monocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, affects expression9
methylmercuric chlorideincreases expression, affects cotreatment3
trichostatin Aaffects cotreatment, decreases expression, increases expression3
aristolochic acid Idecreases expression1
triphenyl phosphateaffects expression1
propionaldehydeincreases expression1
bisphenol Aaffects cotreatment, decreases methylation, increases methylation1
lead acetateincreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
arseniteincreases methylation1
sodium arsenitedecreases expression1
butyraldehydeincreases expression1
didecyldimethylammoniumdecreases expression1
aflatoxin B2increases methylation1
nickel sulfatedecreases expression1
pentanalincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment, increases expression1
nutlin 3affects cotreatment, increases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
dorsomorphinaffects cotreatment, increases expression, decreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Air Pollutantsdecreases expression, increases abundance1
Aldehydesincreases expression1
Amphotericin Bdecreases expression1
Benzo(a)pyreneincreases methylation1
Dactinomycinaffects cotreatment, increases expression1
Estradiolaffects cotreatment, decreases expression1
Nickeldecreases expression1
Quercetindecreases expression1
Rotenonedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.